+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05797519

Evaluation of the VDyne Transcatheter Tricuspid Valve Replacement System for Treating Tricuspid Regurgitation Safety and Efficacy Clinical Study

Led by VDyne, Inc. · Updated on 2026-08-13

120

Participants Needed

21

Research Sites

208 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to collect safety and effectiveness data for the VDyne Transcatheter Tricuspid Valve Replacement System as a treatment for tricuspid regurgitation. The study supports obtaining the Conformit Europenne CE Mark for this device. It focuses on adults with severe tricuspid valve regurgitation and evaluates the devices impact on heart valve function and patient health. Participants will receive treatment using the VDyne System during the study. This investigational device is designed to replace the tricuspid valve via a catheter-based procedure. The study follows a single group receiving the VDyne System, with assessments occurring from baseline through up to one year after the procedure to monitor safety and treatment effects. Throughout the trial, participants will be monitored for major adverse events related to the device or procedure, changes in valve leakage, symptom status, functional ability measured by a six-minute walk test, and quality of life. Evaluations include imaging reviews and clinical assessments at 1 month, 3 months, 6 months, and 1 year post-procedure. The total study duration spans several years, with primary safety outcomes assessed within 30 days and longer-term follow-up extending to one year after treatment.

CONDITIONS

Brief Title

Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation

Research Team

V

Vinny Podichetty

P

Pree Bassi

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here